259 related articles for article (PubMed ID: 2056279)
21. Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL.
Dolstra H; Fredrix H; Preijers F; Goulmy E; Figdor CG; de Witte TM; van de Wiel-van Kemenade E
J Immunol; 1997 Jan; 158(2):560-5. PubMed ID: 8992968
[TBL] [Abstract][Full Text] [Related]
22. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens.
Mutis T; Verdijk R; Schrama E; Esendam B; Brand A; Goulmy E
Blood; 1999 Apr; 93(7):2336-41. PubMed ID: 10090944
[TBL] [Abstract][Full Text] [Related]
24. HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand.
Gillespie G; Mutis T; Schrama E; Kamp J; Esendam B; Falkenburg JF; Goulmy E; Moss P
Hematol J; 2000; 1(6):403-10. PubMed ID: 11920221
[TBL] [Abstract][Full Text] [Related]
25. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
[TBL] [Abstract][Full Text] [Related]
26. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation.
Goulmy E; Schipper R; Pool J; Blokland E; Falkenburg JH; Vossen J; Gratwohl A; Vogelsang GB; van Houwelingen HC; van Rood JJ
N Engl J Med; 1996 Feb; 334(5):281-5. PubMed ID: 8532022
[TBL] [Abstract][Full Text] [Related]
27. Studies on the mechanism of tolerance or graft-versus-host disease in allogeneic bone marrow recipients at the level of cytotoxic T-cell precursor frequencies.
Irschick EU; Hladik F; Niederwieser D; Nussbaumer W; Holler E; Kaminski E; Huber C
Blood; 1992 Mar; 79(6):1622-8. PubMed ID: 1547351
[TBL] [Abstract][Full Text] [Related]
28. Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling.
Lienert-Weidenbach K; Valiante NM; Brown C; White C; Johnston-Dow L; McGinnis M; Krausa P; Lakes DM; Wolf JL; Blume KG; Parham P
Biol Blood Marrow Transplant; 1997 Nov; 3(5):255-60. PubMed ID: 9450920
[TBL] [Abstract][Full Text] [Related]
29. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens.
Voogt PJ; Fibbe WE; Marijt WA; Goulmy E; Veenhof WF; Hamilton M; Brand A; Zwann FE; Willemze R; van Rood JJ
Lancet; 1990 Jan; 335(8682):131-4. PubMed ID: 1967432
[TBL] [Abstract][Full Text] [Related]
30. The role of B7 costimulation by murine acute myeloid leukemia in the generation and function of a CD8+ T-cell line with potent in vivo graft-versus-leukemia properties.
Boyer MW; Vallera DA; Taylor PA; Gray GS; Katsanis E; Gorden K; Orchard PJ; Blazar BR
Blood; 1997 May; 89(9):3477-85. PubMed ID: 9129056
[TBL] [Abstract][Full Text] [Related]
31. The progenitor cell inhibition assay to measure the anti-leukemic reactivity of T cell clones against acute and chronic myeloid leukemia.
van der Hoorn MA; van Luxemburg-Heijs SA; van Bergen CA; Bongaerts R; Willemze R; Falkenburg JH
Methods; 2003 Oct; 31(2):113-9. PubMed ID: 12957568
[TBL] [Abstract][Full Text] [Related]
32. High frequencies of cytotoxic T cell precursors against minor histocompatibility antigens after HLA-identical BMT: absence of correlation with GVHD.
de Bueger M; Bakker A; Bontkes H; van Rood JJ; Goulmy E
Bone Marrow Transplant; 1993 May; 11(5):363-8. PubMed ID: 8504270
[TBL] [Abstract][Full Text] [Related]
33. Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells.
Voogt PJ; Goulmy E; Veenhof WF; Hamilton M; Fibbe WE; Van Rood JJ; Falkenburg JH
J Exp Med; 1988 Dec; 168(6):2337-47. PubMed ID: 3199071
[TBL] [Abstract][Full Text] [Related]
34. Expression of human minor histocompatibility antigen on cultured kidney cells.
Beck Y; Sekimata M; Nakayama S; Müller GA; Müller CA; Yamamoto J; Nagao T; Uchida H; Akiyama N; Kariyone A
Eur J Immunol; 1993 Feb; 23(2):467-72. PubMed ID: 8382163
[TBL] [Abstract][Full Text] [Related]
35. Clinical consequences of sensitisation to minor histocompatibility antigens before allogeneic bone marrow transplantation.
Rufer N; Starobinski M; Chapuis B; Gratwohl A; Jeannet M; Helg C; Roosnek E
Bone Marrow Transplant; 1998 Nov; 22(9):895-8. PubMed ID: 9827818
[TBL] [Abstract][Full Text] [Related]
36. Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates.
Georges GE; Lesnikova M; Storb R; Yunusov M; Little MT; Nash RA
Biol Blood Marrow Transplant; 2003 Apr; 9(4):234-42. PubMed ID: 12720216
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.
Beck Y; Satz L; Takamiya Y; Nakayama S; Ling L; Ishikawa Y; Nagao T; Uchida H; Tokunaga K; Müller C
J Exp Med; 1995 Jun; 181(6):2037-48. PubMed ID: 7759996
[TBL] [Abstract][Full Text] [Related]
38. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.
Vogt MH; van den Muijsenberg JW; Goulmy E; Spierings E; Kluck P; Kester MG; van Soest RA; Drijfhout JW; Willemze R; Falkenburg JH
Blood; 2002 Apr; 99(8):3027-32. PubMed ID: 11929796
[TBL] [Abstract][Full Text] [Related]
39. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
Voogt PJ; Falkenburg JH; Fibbe WE; Veenhof WF; Hamilton M; Van Krimpen BA; Bolhuis RL
J Immunol; 1989 Mar; 142(5):1774-80. PubMed ID: 2521886
[TBL] [Abstract][Full Text] [Related]
40. Viral peptide specific cytotoxic T lymphocytes are of high avidity to host-MHC but only low avidity to donor-MHC after allogeneic bone marrow transplantation.
Kyburz D; Speiser DE
Transpl Immunol; 1995 Jun; 3(2):143-50. PubMed ID: 7582905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
